Exicure

Exicure Net Debt / EBITDA

The Net Debt to EBITDA of Exicure (XCUR) as of Oct 18, 2026 is 0.35. In the previous year, Net Debt to EBITDA was 0.68 — a change of -48.06% (lower).

Net Debt / EBITDA

0.35

YoY

-48.06%

Last updated:

Net Debt to EBITDA of Exicure is 2025 0.35 . Net Debt to EBITDA of Exicure was 2024 0.68 . It decreases by -48.06% lower compared to the previous year.

The Exicure Net Debt / EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Debt / EBITDA
Date
Net Debt / EBITDA
Jan 1, 2018
0.97 USD
Jan 1, 2019
3.96 USD
Jan 1, 2020
2.25 USD
Jan 1, 2021
0.39 USD
Jan 1, 2022
0.71 USD
Jan 1, 2023
-0.39 USD
Jan 1, 2024
0.68 USD
Jan 1, 2025
0.35 USD
The Exicure Net Debt / EBITDA history
YEARNet Debt / EBITDAYoY
0.35-48.06%
0.68-274.18%
-0.39-155.02%
0.71+81.69%
0.39-82.68%
2.25-43.14%
3.96+309.64%
0.97-52.74%
2.05+141.30%
0.85—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Exicure Stock analysis

What does Exicure do? Exicure Inc., headquartered in Chicago, Illinois, is a clinical-stage biotechnology company focused on developing therapeutics based on spherical nucleic acid (SNA) technology. The company operates in the Health Care sector, targeting immuno-oncology, genetic disorders, and inflammatory conditions. Its pipeline includes AST-008 for cancer treatment, XCUR-FXN for Friedreich’s ataxia, and XCUR17 for inflammatory disorders and hair loss. Listed on May 9, 2018, Exicure employs 8 full-time staff as of the latest data. Exicure is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Exicure stock

Net Debt to EBITDA of Exicure is 0.35 in 2025.

Net Debt to EBITDA of Exicure changed from 0.68 to 0.35, representing a -48.06% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Debt to EBITDA Exicure since 2006 – with annual values, charts, and detailed analysis.

Net Debt/EBITDA measures how many years it would take to repay all debt using EBITDA. Lower ratios indicate stronger debt repayment capacity.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Debt to EBITDA's Exicure with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Exicure

All Key Metrics — Exicure